Nabla Bio vs Oracle Health
Side-by-side comparison of AI visibility scores, market position, and capabilities
AI antibody design platform targeting undruggable GPCRs and ion channels; $37M raised with $550M+ in AstraZeneca, BMS, and Takeda partnership milestones led by Radical Ventures.
About
Nabla Bio is a Harvard spinout biotech company using AI-driven generative protein design to develop antibodies against multipass membrane proteins — a class of drug targets including GPCRs (G protein-coupled receptors), ion channels, and transporters that are implicated in numerous diseases but have been historically undruggable with antibody therapies due to their complex 3D structure embedded in the cell membrane. A Y Combinator graduate, Nabla Bio raised $37 million total including a $26 million Series A led by Radical Ventures, and secured strategic collaborations with AstraZeneca, Bristol Myers Squibb, and Takeda worth $550 million+ in upfront and milestone payments plus royalties.
Oracle Corporation's healthcare IT division (rebranded Cerner, $28.3B acquisition 2022); #2 US hospital EHR, VA/DoD federal EHR program, OCI cloud migration + ambient clinical AI competing with Epic Systems.
About
Oracle Health is the healthcare technology business unit of Oracle Corporation (NYSE: ORCL) — providing electronic health records (EHR), clinical workflow management, health information exchange, revenue cycle management, and population health analytics to hospitals, health systems, physician practices, ambulatory clinics, and government health agencies globally — operating as the rebranded Cerner Corporation following Oracle's $28.3 billion acquisition of Cerner in June 2022, the largest acquisition in Oracle's history. Oracle Health's EHR platform (the Cerner Millennium clinical information system) powers clinical documentation, physician order entry, nursing workflows, medication administration, and patient care coordination for approximately 30% of US hospitals — making Oracle Health the second-largest EHR vendor in the US hospital market after Epic Systems. A major integration program is underway to migrate Cerner's clinical applications to Oracle Cloud Infrastructure (OCI), enabling Oracle Health to leverage Oracle's cloud scale, Oracle's AI capabilities (generative AI for clinical documentation, ambient listening for physician notes), and Oracle's database performance advantages for health record analytics. Oracle Corporation named Clay Magouyrk and Mike Sicilia as co-CEOs in 2025 (replacing Safra Catz), positioning Oracle Health's clinical platform to benefit from the next-generation Oracle leadership team's emphasis on cloud and AI transformation.
AI Visibility Head-to-Head
Key Details
Capabilities & Ecosystem
Capabilities
Also Compare
Track AI Visibility in Real Time
Monitor how your brand performs across ChatGPT, Gemini, Perplexity, Claude, and Grok daily.